Cadence Capital Management Lowered Colgate Palmolive Co (CL) Stake; Immune Design (IMDZ) Shorts Up By 18.26%

January 23, 2018 - By wolcottdaily

Cadence Capital Management Llc decreased Colgate Palmolive Co (CL) stake by 12.37% reported in 2017Q3 SEC filing. Cadence Capital Management Llc sold 17,103 shares as Colgate Palmolive Co (CL)’s stock rose 3.95%. The Cadence Capital Management Llc holds 121,129 shares with $8.82M value, down from 138,232 last quarter. Colgate Palmolive Co now has $67.74B valuation. The stock decreased 0.31% or $0.24 during the last trading session, reaching $77.14. About 643,631 shares traded. Colgate-Palmolive Company (NYSE:CL) has risen 6.23% since January 23, 2017 and is uptrending. It has underperformed by 10.47% the S&P500.

Immune Design Corporation (NASDAQ:IMDZ) had an increase of 18.26% in short interest. IMDZ’s SI was 1.59 million shares in January as released by FINRA. Its up 18.26% from 1.35 million shares previously. With 604,700 avg volume, 3 days are for Immune Design Corporation (NASDAQ:IMDZ)’s short sellers to cover IMDZ’s short positions. The stock increased 1.37% or $0.05 during the last trading session, reaching $3.7. About 35,439 shares traded. Immune Design Corp. (NASDAQ:IMDZ) has declined 40.11% since January 23, 2017 and is downtrending. It has underperformed by 56.81% the S&P500.

Since August 1, 2017, it had 2 insider buys, and 6 sales for $21.80 million activity. Shares for $13,885 were sold by Brady Stephen R. The insider COLUMN GROUP L P bought 2.68M shares worth $10.99 million. Gombotz Wayne sold 10,000 shares worth $114,336. Another trade for 1,986 shares valued at $8,282 was made by ter Meulen Jan Henrik on Thursday, January 4. 7,970 Immune Design Corp. (NASDAQ:IMDZ) shares with value of $33,247 were sold by Paya Carlos V. On Friday, October 27 Svennilson Peter bought $10.99 million worth of Immune Design Corp. (NASDAQ:IMDZ) or 2.68 million shares. $2,816 worth of Immune Design Corp. (NASDAQ:IMDZ) was sold by Yurasov Sergey on Thursday, January 4.

Investors sentiment decreased to 1.27 in Q3 2017. Its down 1.17, from 2.44 in 2017Q2. It fall, as 5 investors sold Immune Design Corp. shares while 21 reduced holdings. 13 funds opened positions while 20 raised stakes. 11.88 million shares or 8.39% more from 10.96 million shares in 2017Q2 were reported. Abingworth Llp accumulated 2.52% or 352,300 shares. State Street Corporation owns 221,490 shares. Panagora Asset Management holds 198,926 shares or 0.01% of its portfolio. Alliancebernstein L P holds 12,100 shares or 0% of its portfolio. The New York-based Citigroup has invested 0% in Immune Design Corp. (NASDAQ:IMDZ). The Illinois-based Zacks Invest Management has invested 0.03% in Immune Design Corp. (NASDAQ:IMDZ). Vanguard Grp Inc holds 0% or 602,720 shares in its portfolio. Fmr Ltd Limited Liability Company reported 0% in Immune Design Corp. (NASDAQ:IMDZ). 33,056 were accumulated by Personal. Manufacturers Life Insurance Commerce The holds 0% or 14,822 shares in its portfolio. Federated Pa owns 0% invested in Immune Design Corp. (NASDAQ:IMDZ) for 484 shares. California-based Eam Invsts Ltd Liability Corp has invested 0.05% in Immune Design Corp. (NASDAQ:IMDZ). Commercial Bank Of America Corporation De reported 0% in Immune Design Corp. (NASDAQ:IMDZ). Franklin Resource holds 0% or 781,753 shares in its portfolio. Geode Mngmt Limited Liability reported 123,522 shares or 0% of all its holdings.

Among 5 analysts covering Immune Design (NASDAQ:IMDZ), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. Immune Design had 10 analyst reports since August 18, 2015 according to SRatingsIntel. On Thursday, October 5 the stock rating was maintained by Jefferies with “Buy”. The rating was maintained by Jefferies with “Buy” on Wednesday, August 10. The stock of Immune Design Corp. (NASDAQ:IMDZ) earned “Buy” rating by Jefferies on Wednesday, September 9. The stock of Immune Design Corp. (NASDAQ:IMDZ) earned “Outperform” rating by Leerink Swann on Tuesday, August 18. The stock has “Market Perform” rating by Wells Fargo on Wednesday, October 18. The stock has “Buy” rating by Jefferies on Monday, June 26. Jefferies maintained Immune Design Corp. (NASDAQ:IMDZ) rating on Monday, September 4. Jefferies has “Buy” rating and $18.0 target. Cowen & Co maintained Immune Design Corp. (NASDAQ:IMDZ) on Tuesday, June 6 with “Buy” rating.

Among 25 analysts covering Colgate-Palmolive (NYSE:CL), 6 have Buy rating, 1 Sell and 18 Hold. Therefore 24% are positive. Colgate-Palmolive had 63 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of Colgate-Palmolive Company (NYSE:CL) has “Hold” rating given on Friday, September 4 by Zacks. The firm earned “Hold” rating on Monday, November 2 by Deutsche Bank. The rating was maintained by RBC Capital Markets with “Hold” on Tuesday, August 1. RBC Capital Markets maintained Colgate-Palmolive Company (NYSE:CL) rating on Tuesday, September 5. RBC Capital Markets has “Hold” rating and $74.0 target. The stock of Colgate-Palmolive Company (NYSE:CL) has “Neutral” rating given on Friday, July 31 by UBS. Barclays Capital maintained it with “Equal-Weight” rating and $70 target in Monday, March 21 report. The firm earned “Hold” rating on Friday, October 6 by RBC Capital Markets. SunTrust upgraded the stock to “Buy” rating in Wednesday, October 11 report. Stifel Nicolaus maintained Colgate-Palmolive Company (NYSE:CL) rating on Monday, September 18. Stifel Nicolaus has “Hold” rating and $75.0 target. The rating was maintained by Jefferies with “Hold” on Thursday, January 4.

Investors sentiment is 0.9 in 2017 Q3. Its the same as in 2017Q2. It is the same, as 52 investors sold CL shares while 437 reduced holdings. only 92 funds opened positions while 350 raised stakes. 617.24 million shares or 0.04% less from 617.46 million shares in 2017Q2 were reported. Umb Comml Bank N A Mo, a Missouri-based fund reported 34,412 shares. Salem Inv Counselors Inc holds 100,495 shares or 0.86% of its portfolio. Eagle Ridge Investment stated it has 24,920 shares. Fairfield Bush And reported 10,000 shares or 0.23% of all its holdings. S&T Savings Bank Pa accumulated 0.42% or 32,295 shares. Dowling & Yahnke Ltd Liability holds 70,875 shares. Colony Gru Ltd Liability Corporation stated it has 0.1% of its portfolio in Colgate-Palmolive Company (NYSE:CL). Virginia-based Davenport & Limited Liability has invested 0.04% in Colgate-Palmolive Company (NYSE:CL). Winfield Assocs Incorporated has 0.01% invested in Colgate-Palmolive Company (NYSE:CL) for 190 shares. Moreover, Neuberger Berman Lc has 0.04% invested in Colgate-Palmolive Company (NYSE:CL) for 439,541 shares. 16,952 are owned by Granite Investment Prns Limited Liability. Commonwealth Fincl Bank Of Australia holds 0.45% of its portfolio in Colgate-Palmolive Company (NYSE:CL) for 634,577 shares. Azimuth Capital Mngmt Limited Liability Corporation stated it has 126,343 shares or 0.69% of all its holdings. Barnett And Company Inc owns 0.03% invested in Colgate-Palmolive Company (NYSE:CL) for 800 shares. Moreover, Bancorp Of The Ozarks has 0.41% invested in Colgate-Palmolive Company (NYSE:CL).

Since August 1, 2017, it had 0 insider buys, and 8 selling transactions for $11.05 million activity. $539,694 worth of Colgate-Palmolive Company (NYSE:CL) was sold by Daniels Jennifer on Wednesday, December 13. Another trade for 5,057 shares valued at $363,664 was made by HANCOCK ELLEN M on Tuesday, August 1. Marsili Daniel B sold $1.00M worth of Colgate-Palmolive Company (NYSE:CL) on Tuesday, August 15. $5.30M worth of Colgate-Palmolive Company (NYSE:CL) shares were sold by HICKEY DENNIS J. 35,000 shares were sold by MOISON FRANCK J, worth $2.50M. On Tuesday, August 15 the insider Verduin Patricia sold $273,868. HUSTON JOHN J sold $999,064 worth of stock or 14,000 shares.

Analysts await Colgate-Palmolive Company (NYSE:CL) to report earnings on January, 26. They expect $0.75 earnings per share, 0.00% or $0.00 from last year’s $0.75 per share. CL’s profit will be $658.58M for 25.71 P/E if the $0.75 EPS becomes a reality. After $0.73 actual earnings per share reported by Colgate-Palmolive Company for the previous quarter, Wall Street now forecasts 2.74% EPS growth.

Cadence Capital Management Llc increased Consolidated Edison Inc (NYSE:ED) stake by 5,570 shares to 19,582 valued at $1.58M in 2017Q3. It also upped Agnc Invt Corp stake by 15,104 shares and now owns 48,773 shares. Abraxas Pete Corp (NASDAQ:AXAS) was raised too.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>